[1] 余兰,李腊梅,程向群.肿瘤患者深部真菌医院感染现状调查[J].中华医院感染学杂志,2003,13(2):116-117.
[2] Beck-Segue C,Jarvis WR.Seculartrends in the epidemiology of nosocomial fungal infections in the United States,1980-1990.National Nosocomial Infections Surveillance System[J].J Infect Dis,1993,167(5):1247-1251.
[3] Bader MS,LaiS M,Kumar V,et al.Candidemia in patients with diabetesmellitus:epidemiology and predictors of mortality[J].Scand J Infect Dis,2004,36(11-12):860-864.
[4] 黄晓军.重视侵袭性真菌感染的诊治[J].中国实用内科杂志,2006,26(1):52-53.
[5] WisPlinghoff H,Bisehoff T,Tallent SM,et al.Nosoeomialbloodst ream infections in US hospitals:analysis of 24,179 cases from a Prospective nationwide surveillance study[J].Clinlnfect Dis,2004,39(3):309-317.
[6] P Munoz,J Guinea,E Bouza.Update on invasive aspergillosis:clinical and diagnostic aspects[J].Clin Microbiol Infect,2006,12(57):24-39.
[7] White PL,Linton CJ,Peny MD,et al.The evolution and evaluaLion of a whole blood Polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a rou tine clinical setting[J].Clin Infect Dis,2006,42(4),479-489.
[8] G Quinds.New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi[J] Clin Microblol Infect,2006,12 (17):40-52.
[9] 钟南山,叶枫深部真菌感染:新的挑战与展望[J].中华结核和呼吸杂志,2006,29 (5):289-290.
[10] 戴春梅,周建党,伍勇临床深部真菌感染的分布与耐药性分析[J].中国抗生素杂志,2006,31(5):314-315.
[11] Chamilos G,Luna M,Lewis RE,et al.Invasive fungal infections inpatients with hematologic malignancies in a tertiary care cancer center:an autopsy study over a 15 year period (1989-2003)[J].Haematologlea,2006,91(7):986-989.
[12] 祝贺,杨蓉娅,王文岭.真菌组成成分及代谢产物检测在真菌病诊断中的应用进展[J].中国真菌学杂志,2007,2(2),119-121.
[13] Levin J,Poore T.E,Zauber N.P et al.Detection of endotoxin in the blood of patient with sepsis due to gram-negative bacteria[J].N Engl J Med,1970,283(10):1313-1316.
[14] Shimizu A,Oka H,Matsuda T,et al.(1-3-S-D-glucan is a di-agnostic and negative prognostic marker for Pneumocystis and carinii pneumonia in patients with connective tissue disease[J].Clin Exp Rheumatol,2005,23(5):678680.
[15] Hope WW,Walsh TJ,Denning DW.Laboratory diagnosis of invasive aspergillosis[J].Lancet Infect Dis,2005,5(10):609-622.
[16] Paws C,Ponton J,Palocio AD.Contribution of(1-3)-S-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergifos is in neurpenic adult patients; a comparison with serial screening for circulating galactomannan[J].J Clin Microbiol,2005,43(1):299-305.
[17] Pickering JW,Sant HW,Bowles CA,et al.Evaluation of a(1-3)-p-D-glucan assay for diagnosis of invasive fungal infections[J].J Clin Microbiol,2005,43(12):5957-5962.
[18] 赵勇,王红,任爱民.等.血浆B-1,3-D-葡聚糖对深部真菌感染诊断的研究[J] 中国真菌学杂志,2007,2(4):202-206.
[19] Yoshida M,Roth R I,Crunfeld C,et al.Soluble(1-3)-beta-D-glucan purified from Candida albicans:biologic effects and distribution in blood and organs in rabbits[J].J Lab Clin Med,1996,128(1):103-114.
[20] Herbrecht R,Letscher-Bru V,Oprea C et al.Aspergillus 47 galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients[J].J Clin Oncol,2002,20(7):1898-1906.
[21] Boutboul F,Alberti C,Leblanc T,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients; increasing antigenemia is associated with progressive disease[J].Clin Infect Dis,2002,34(7):939-943
[22] Chambon PC,Costa JM,Chaumette MT,et al.Galactomannan and polymerise chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia[J].J Infect,2001,43(3):213-214.
[23] Franklyn KM,Suzuki R,Holland JF.Cloning and nucleotide sequence analysis of the Candida albicans enolase gene[J].ITEMS Microbiol Lett,1993,111(1):101-108.
[24] Kato H,Nakao A,Kambe T,et al.The quantitative assay of(1-》3)-beta-D-glucan in culture medium of Candida albicans using G-test[J].Nippon Geka Gakkai Zasshi,1993,94 (4):329-333.
[25] Carram P,Plebani M,Varagnolo MA,et al.A new immunoassay for the measurement of myoglobin in serum[J].J Clin Lab Anal,1994,8(2):70-75.
[26] Sundstrom P,Aliaga GR.A subset of proteins found in culture supernatants of Candida albicans includes the abundant,immunodominant,glycolytic enzyme enolase[J].J Infect Dis,1994,169(2):452456.
[27] Wojcicka KI,Golczak M.Enolase from Candida albican -purification and characterization[J].Comp Biochem Physiol Biochem Mol Biol,2000,126(1):109-120.
[28] Misaki H,Iwasaki H,Ueda T.A comparison of the specificity and sensitivity of two Candida antigen assay systems for the diagnosis of deep candidiasis in patients with hematologic diseases[J].Med Sci Monit,2003,9(2);MTl-7
[29] Musher B,Fredrieks D,Leisenring W,et al.Aspergillus galactomannan enzyme immunoassay and qu antitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavagc fluid[J].J Clin Microbiol,2004,42 (12):5517-5522
[30] Jordanides NE,A llan EK,McLintock LA,et al.A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients[J] Bone Marrow Transplant,2005,35(4):389-395.
[31] Hsiao CR,Huang L,Bouchara JP,et al.Identification of medically important molds by all oligonucleotide assay[J].J Clin Microbiol,2005,43 (8):3760-3768. |
